Elevate Medical Affairs Podcast Channel: Recent Episodes
Medical Affairs Professional Society
Podcast channel for the Medical Affairs Professional Society (MAPS). Global excellence in Medical Affairs from today's leaders.
Join Dr. Aarathi Cholkeri-Singh, Executive Director & Chief Medical Officer – North America, Karl Storz and Veeva experts for a practical discussion on establishing and scaling a high-impact medtech medical affairs function, even during hiring freezes. We’ll share real-world strategies for navigating EU MDR requirements and building diverse teams that drive clear business value across various organizational structures. Finally, we will share new report findings on the function’s current state to help you quantify your strategic contribution, accelerate enterprise growth, and transition from functional execution to a core leadership pillar.
Welcome to Episode 4 of the SciTech Critical Evaluation of Literature and AI Series: “Smarter Summaries, Better Decisions: AI Across Medical Affairs"
Medical Affairs teams handle a flood of scientific data, so how can AI help turn complexity into clarity? Join experts from the MAPS Scientific & Technical Knowledge Domain to discover how AI tools evaluate evidence for diverse functions, from field teams to HEOR and publications.
In this session, you’ll learn practical strategies for creating concise, decision-ready summaries and explore why context and clinical relevance must guide every AI-driven workflow. If you want to leverage AI to evaluate evidence, podcast is for you!
Learning Objectives:
- Describe how AI tools adapt evidence evaluation for different Medical Affairs functions
- Explore how field medical, medical communications, publications, medical information, and HEOR teams can prompt the same data set differently to generate outputs tailored to their specific needs.
- Demonstrate strategies to create concise, decision-ready summaries using AI
- Learn practical prompting and structuring techniques that convert complex scientific literature into clear, stakeholder-specific deliverables that support better strategic and scientific decisions.
- Explain why context and applicability are essential in AI-enabled evidence workflows
- Understand how role-specific context, intended use, and decision impact must guide both the prompting and interpretation of AI-generated outputs.
Hear more from the Scientific & Technical Knowledge Domain through their position paper: "Safeguarding Scientific Rigor in the Critical Evaluation of Literature"
Welcome to Episode 3 of the SciTech Critical Evaluation of Literature and AI Series: “Humans + AI: Making Sense of Scientific Papers at Scale"
AI can read hundreds of scientific papers in minutes, but can it truly understand them? Join experts from the MAPS Scientific & Technical Knowledge Domain to explore how artificial intelligence is reshaping literature review in Medical Affairs.
In this session, you’ll learn what AI can and cannot do with scientific content, uncover practical applications of leading tools like CoPilot and Notebook LM. We’ll also tackle common risks such as hallucinations and lack of context, and share strategies to validate AI outputs while keeping clinical judgment front and center. If you want to harness AI without losing the human touch, this webinar is for you!
Learning Objectives:
- Understand what AI can—and cannot—do with scientific literature
- Explain how AI processes papers using NLP and LLMs, and why clinical judgment remains essential.
- Explore practical applications of leading AI tools
- Review the capabilities, pros, and cons of tools like CoPilot and Notebook LM for Medical Affairs workflows.
- Recognize limitations and risks in AI-driven literature review
- Identify common issues such as hallucinations, lack of context, and strategies to validate AI outputs.
Hear more from the Scientific & Technical Knowledge Domain through their position paper: "Safeguarding Scientific Rigor in the Critical Evaluation of Literature"
Welcome to Episode 2 of the SciTech Critical Evaluation of Literature and AI Series: “Literature Never Sleeps: Staying Ahead Without Burning Out"
Literature never sleeps and neither do the challenges of keeping Medical Affairs teams up to date.
Join experts from the MAPS Scientific & Technical Knowledge Domain to discover practical strategies for managing the deluge of data. We’ll explore how AI can accelerate evidence synthesis while highlighting its limitations and the critical role of human judgment. If you’re looking for smarter ways to stay current, this podcast is for you!
Learning Objectives:
- Identify key challenges in keeping Medical Affairs teams current
- Understand the impact of preprints, grey literature, bibliometrics, and predatory journals on evidence appraisal.
- Evaluate the role and limitations of AI in literature review
- Recognize how AI can accelerate evidence evaluation while appreciating the need for human judgment and safeguards against errors.
- Apply best practices for confidentiality and critical assessment of AI outputs
- Learn practical steps to ensure secure data handling and train teams to validate AI-generated insights effectively.
Hear more from the Scientific & Technical Knowledge Domain through their position paper: "Safeguarding Scientific Rigor in the Critical Evaluation of Literature"
Welcome to Episode 1 of the SciTech Critical Evaluation of Literature and AI Series: “Evidence Unlocked: Separating Gold from Gravel"
Not all evidence is created equal, so how do you separate gold from gravel? Join experts from the MAPS Scientific & Technical Knowledge Domain for a fast-paced session designed to simplify critical appraisal for busy professionals. In just a few minutes, you’ll learn how to navigate the hierarchy of evidence and apply practical frameworks. We’ll also share a step-by-step approach for rapid evaluation, helping you assess robustness, and clinical relevance without getting lost in complexity. If you want to make smarter, faster evidence-based decisions, this podcast is for you!
Learning Objectives:
- Understand the hierarchy of evidence
- Explain the differences between randomized controlled trials (RCTs), observational studies, real-world data, and preprints, and why they matter for evidence quality.
- Recognize key frameworks for critical appraisal
- Introduce GRADE, PRISMA, and CONSORT as practical tools for evaluating robustness, reproducibility, and clinical relevance.
- Apply a rapid evaluation approach
- Provide a simple, step-by-step method for quickly assessing scientific literature without compromising rigor.
Hear more from the Scientific & Technical Knowledge Domain through their position paper: "Safeguarding Scientific Rigor in the Critical Evaluation of Literature"
In the final part of this 3-part series, experts from the MAPS Leadership and Management Domain wrap up their discussion on understanding change. How does it impact our teams, and how can our leaders guide their teams through change?
Through this episode, Medical Affairs professionals may gain a better understanding of why change feels so hard right now and learn about what we can do to support each other and really thrive during these times of uncertainty.
Medical affairs teams are implementing AI tools to take advantage of the transformative efficiencies they bring, and successful AI adoption requires responsible AI governance, including managing copyright risk.
In this podcast, Lauren Tulloch, Vice President and Managing Director, CCC, addresses the unique challenges facing medical affairs professionals whose daily work with scientific articles and other published content increasingly intersects with AI and complex copyright considerations.
Tulloch will guide listeners through the tangled legal landscape around AI, discussing court cases and proposed regulation. She will also debunk common copyright misconceptions and provide actionable insights for navigating copyright compliance in an AI-driven world.
Listeners will learn about what to consider when choosing, designing, and deploying AI-powered solutions, and Tulloch will also lay out practical strategies for managing copyright risk while taking advantage of the efficiencies and other benefits AI promises.
In Part 2 of this 3-part series, experts from the MAPS Leadership and Management Domain continue this discussion on understanding change. How does it impact our teams, and how can our leaders guide their teams through change?
Through this episode, Medical Affairs professionals may gain a better understanding of why change feels so hard right now and learn about what we can do to support each other and really thrive during these times of uncertainty.
Building and demonstrating medical impact is becoming a central priority for organizations seeking to deliver meaningful outcomes for patients, healthcare systems, and society. But what does it take to design, implement, and sustain an effective impact framework within a medical affairs setting? In this podcast, we bring together medical leaders who have successfully navigated this journey in their own organizations.
Through an engaging discussion, they share the motivations that drove their initiatives - whether responding to unmet needs, seizing strategic opportunities, or adapting to evolving organizational contexts. Listeners will hear practical insights into how frameworks were designed, the principles that guided them, and how approaches were tailored to align with specific structures, cultures, and therapeutic areas.
The conversation also explores real-world outcomes: how impact is measured and recognized, what changes have emerged since implementation, and the role of data and technology in accelerating progress. Leaders candidly reflect on unexpected challenges and benefits, while offering practical advice for peers who are starting or refining their own frameworks.
Looking ahead, our speakers share their perspectives on the future evolution of impact capabilities-and the enablers that will drive success in the years to come.
As Medical Affairs teams face rising content volumes, tighter timelines, and increasing complexity, many leaders are asking the same question: Can AI meaningfully improve the MLR review process—and if so, where do we start? In this practical, scenario-based session, members of the MAPS Medical Governance and Compliance Domain will explore high value GenAI use cases and where it can supplement human judgment. We’ll also discuss governance essentials, and a logical roadmap for responsible adoption, giving attendees the clarity and confidence needed to begin their own AI-enabled transformation.
LEARNING OBJECTIVES:
- Understand the current situation and pain points with MLR
- Understand how GenAI tools can be responsibly introduced into the MLR workflow, highlighting high-value use cases and realistic implementation steps
- Understand key governance and implementation considerations
SPEAKERS
Moderator
Jaymesh Patel, Director & Strategic Partner - Global Medical Ethics, Astrazeneca
Speaker 1
Anneka Kapur, Senior Final Medical Signatory and Compliance Lead, Lundbeck
Speaker 2
Dr William Mwiti, Biopharma Medical Head: Sub Saharan & French Speaking Africa, Astrazeneca
Health misinformation is a critical threat to global public health. It erodes confidence in vaccines and medicines, fuels pandemic denialism, promotes unproven treatments, and undermines public health efforts. Medical Affairs sits at the centre of this challenge. We have a clear ethical responsibility to ensure patients make informed, evidence-based decisions about their care, and to equip healthcare professionals with the information and tools needed to address misinformation in the clinical setting. However, this approach carries inherent time and resource limitations.
In this episode, we explore the role of Digital Opinion Leaders (DOLs) as a core pillar of modern healthcare communications. DOLs have the power to shape conversations, steer search behaviours, and can either amplify misinformation or help correct it. We examine the different DOL profiles and personas, discuss best practices for building effective long-term partnerships that leverage their individuality, preferences, and regional specificities, and consider how DOL engagement should be embedded into medical and cross-functional planning.
We will draw on early insights from an ongoing pilot in Sub-Saharan Africa, analysing how patients and healthcare workers use social platforms and messaging apps – enabling us to identify trusted DOLs we can partner with to design effective health education and advocacy programmes.
On today's MAPS "Elevate" episode, we'll deep dive into how Medical Affairs professionals can strengthen their business knowledge, expand their influence across organizations, and position themselves for executive leadership. Through personal stories and practical advice, our speakers reveal how. through working with and absorbing business acumen, they are helping people become more effective and more strategic leaders, and rising within their organizations.
Learning Objectives:
By the end of this podcast, listeners will learn:
- Why business acumen is important
- What the balance is between business and medical needs
- What motivates companies to develop and commercialize a new medicine
- How Medical Affairs adds value
- What qualities make a great partner
Speakers:
Moderator: Michael Kahn, Executive Director, Medical Excellence, Amicus Therapeutics
LINKEDIN: https://www.linkedin.com/in/kahnmichael/
Speaker 1: René Russo, PharmD, President & CEO, Xilio Therapeutics
LINKEDIN: https://www.linkedin.com/in/rene-russo-7488966/
Speaker 2: Ruth du Moulin, PhD, SVP Medical Affairs, Xilio Therapeutics
LINKEDIN: https://www.linkedin.com/in/ruth-du-moulin-phd-472b843/
Learning Objectives:
After listening to this episode, the audience will be able to:
- Describe how a Medical Affairs organization prioritized and implemented AI use cases to address HCP needs through faster, more intuitive, conversational engagement with medical content.
- Identify key considerations for scaling external-facing AI solutions in Medical Affairs, including compliance, governance, and long-term sustainability.
How can Medical Affairs Professionals connect teams, harmonize processes, and enable consistent, high-quality scientific communications?
In today's podcast episode, experts from our Medical Information FAWG explore what it really means to build a truly global medical information function to reach customers across the regions.
For years, patient involvement in drug development was limited to trial participation and post-approval education. But things are evolving. Patients today aren’t just participants—they actively co-build the healthcare ecosystem.
In today's podcast episode, experts from the MAPS Scientific & Technical Knowledge Domain dive into a topic that’s transforming clinical development: Patient engagement.
In the first episode of our series on innovation in Medical Affairs, we focused on the mindset that allows ideas to flourish and on why innovation matters at all. So where do we go from here...
How do we move from ideas to implementation? How do we build systems that make innovation repeatable, measurable, and scalable?
In today's podcast episode, experts from the MAPS Leadership and Management Domain dive deep into the topic of how to convert great ideas into real world value for patients, physicians, and in general, the health care ecosystem.
Medical Affairs is evolving faster than ever. It demands not only execution, but imagination. In fact, innovation in Medical Affairs isn't just needed. It's already happening, and we have the responsibility to guide it with intention.
In today's podcast episode, our speakers explore the foundations of innovation and how having an innovative mindset can help fuel a curious and collaborative Medical Affairs organization to reach new goals.
Join us for a fun look back at the top publications of 2025 — and info your publications team can use to find success beyond only impact factor and citations in 2026.
In this podcast, lead by members of the MAPS Business Knowledge Domain, our experts will:
- Recognize marketing terminology and implications for Medical Affairs activities
- Identify the relevance of market analysis for business decision-making
- Define the importance of competitor analysis and forecasting in marketing and sales
- Recall the value of cross-functional perspectives in decision-making
- Outline the consequences of non-compliance in pharmaceutical activities
- Provide a perspective on how Medical Affairs can bring value to marketing and sales organizations
This three-part podcast explores how Medical Affairs leaders can navigate and lead through disruption with clarity, structure, and resilience.
We explore how to construct and lead an agile, cross-functional crisis team. From defining roles to ensuring aligned decision-making across Medical, Regulatory, and Commercial functions, this episode emphasizes rapid coordination, internal trust, and shared accountability under pressure.
In Part 1 of this 3-part series, experts from the MAPS Leadership and Management Domain discuss understanding change. How does it impact our teams, and how can our leaders guide their teams through change?
Through this episode, leaders and independent contributors may gain a better understanding of why change feels so hard right now and learn about what we can do to support each other and really thrive during these times of uncertainty.
As Medical Affairs leaders, we are tasked with optimizing MA operations and talent through an increasingly multi-generational workforce. Several authors have addressed this issue. This podcast will discuss some of the common issues we are noticing around this topic, and bring relevant applications and examples to the Medical Affairs world, with the aim of understanding and optimizing the skills and contributions of all MA professionals.
References & Resources
- TED Talk: Good Leaders Make People Feel Safe by Simon Sinek
- TED Talk:The Danger of a Single Story by Chimamanda Ngozi Adichie
- Originals: How Non-Conformists Move the Worldby Adam Grant
- Google’s re:Work – tools for psychological safety and team dynamics
- Gentelligence: The Revolutionary Approach to Leading an Intergenerational Workforce by Megan Gerhardt
- TEDx Talk: Why I Love Millennials (and Why You Should Too) by Megan Gerhardt
- Brené Brown — Brown, B. (2018). Dare to lead. Vermilion. https://brenebrown.com/hubs/dare-to-lead/
- Simon Sinek’s TED Talk: Good Leaders Make People Feel Safe
Go to https://medicalaffairs.org/knowledge-center/ for every reference in today's episode!
In today’s rapidly evolving healthcare landscape, leadership in the pharmaceutical industry is entering a new era—one defined by innovation, agility, and purpose-driven impact. This transformation is especially visible in Medical Affairs, where the role is shifting from traditional scientific support to becoming a strategic driver of patient-centered value, cross-functional collaboration, and real-world evidence generation. In this special series, Bagrat Lalayan sits down with prominent industry leaders to explore how modern leaders are navigating global challenges, embracing digital transformation, and redefining success in a more complex and regulated environment. Together, they’ll discuss the skills, mindsets, and strategies required to lead with vision, foster trust, and accelerate innovation—while keeping patient outcomes at the heart of every decision.
What does it actually look like to implement a GenAI solution in a Medical Information department? What are the risks? The benefits? And what should others learn from those who’ve already tested the waters?
In today's "Elevate" episode, our speaker panel, lead by Jennifer Riggins and Steve Casey of the MAPS Digital Strategy FAWG, dives into a topic at the cutting edge of medical information: the use of Generative AI for content creation.
You’re not alone if a strong publication didn’t land. More often than not, the problem isn’t the paper - it’s the data behind your target selection. In this episode, scientific communication expert Mike Cashman (Mavens) and data expert Mike Taylor (Altmetric) share how publications teams are using smarter data to guide journal selection and improve impact.
Learn how real-world signals like citations, clinical uptake, and policy mentions from Dimensions and Altmetric help teams prioritize journals, plan effectively, and track downstream influence. You’ll also hear how this data gets embedded directly into planning workflows, so teams can make confident decisions right where they work.
This is a practical, clear look at how to simplify complex planning, cut through the noise, and make smarter, faster decisions. Whether you’re refining strategy or proving value post-publication, it’s time your tools work as hard as you do.
This three-part podcast explores how Medical Affairs leaders can navigate and lead through disruption with clarity, structure, and resilience.
This episode defines crisis management as a structured, cyclical process: preparedness, response, recovery, and reflection. We discuss how Medical Affairs plays a unique role in translating uncertainty into strategy, maintaining scientific clarity, and protecting external trust through transparent communication.
The Learning Objectives for this podcast are to understand the scope and requirements of the main privacy laws and regulations, covering data types and processing activities including collection, usage, data retention, subjects’ rights and much more.
This podcast also considers the risks and practical application of the regulations in the conduct of various Medical Affairs activities.
This podcast looks at the identification and mitigation of risks in four examples of activities at the Medical/Commercial interface with the intent of strengthening your understanding of how to conduct these activities in a compliant manner. The examples include Medical/Commercial field interactions, patient support programs, advice seeking, and use of artificial intelligence.
From chatbots and content generation to insights mining and decision support, GenAI is moving from buzzword to backbone. In this "Elevate" episode, our hosts Jennifer Riggins & Steve Casey speak to a panel of experts on the frontlines of GenAI implementation to share their hard-won insights.
In this podcast episode, our experts dive into the importance of storytelling in scientific communication, emphasizing the need to balance creativity with accuracy and personalize content for different audiences.
This podcast will provide an overview of results of a poster presented at MAPS Americas in 2025. The title of the poster was "One Team, One Voice: The Impact of Centralized Medical Content Development" and includes results from a survey that was conducted to better understand Medical Affairs (MA) professionals’ strategies for medical content development, utilizing centralized versus decentralized medical content creation, and assess the adoption of structured authoring and AI-enabled solutions to improve scalability, consistency and efficiency in medical content development.
When is the right time to bring your medical information system in-house? What needs to happen once you get there? In this podcast, we dive into scPharmaceuticals’ experience and discuss the milestones that signal a shift. Hear about the case for change, navigating the transition, and the crucial role technology plays in enabling long-term success.
AI offers tremendous benefits but creates new challenges for licensing and research integrity that medical publishers must address. In this MAPS podcast episode, we will discuss the opportunities and challenges of AI in scientific publishing and considerations for medical education.
Expedited publications are essential for rapidly disseminating research findings and accelerating drug approval processes, particularly during public health emergencies. This approach encompasses efficient manuscript development, expedited reviews, and prioritized submissions to scientific journals, ultimately ensuring that critical data swiftly reaches the healthcare community. The urgency for timely information is underscored by examples such as COVID-19, where rapid dissemination played a significant role in updating treatment protocols and informing vaccine practices. However, the podcast also addresses significant challenges faced, including regulatory hurdles, resource constraints, and the risk of compromising research integrity due to pressures for rapid output. Stakeholders such as pharmaceutical companies, regulatory agencies, healthcare providers, and patients can benefit from expedited publications, yet they must navigate the fine balance between speed and quality. By exploring methodologies for successful expedited publishing, including pre-planning, stakeholder engagement, and strategic communication, this podcast highlights the importance of a robust framework for overcoming hurdles and fostering advancements in pharmaceutical research and public health.
The Times Higher Education recently reported that Bluesky has overtaken X in hosting posts related to new academic research. And yet many Medical Affairs teams aren't equipped to maximize the potential of this emerging resources. Here we speak with Mike Taylor, Head of Data Insights, at Altmetric, and Carlos Areia, Senior Data Scientist at Altmetric about the uses of Bluesky in comparison with exiting social media platforms, and how Medical Affairs can leverage this resource for insights, KOL identification/mapping, data dissemination and more.
Believe it or not, the field of Kardashian studies can inform the ways Medical Affair professionals identify and understand influencers and influence in the space of science communications. Here we talk with Mike Taylor, Head of Data Insights at Altmetric, and Carlos Areia, Senior Data Scientist at Altmetric about making sense of what is otherwise certainly nonsense.
In this podcast episode, we share insights from the Wiley annual healthcare professionals survey and interviews on the sources of information they seek and trust. You will learn about how their content needs and preference are evolving and the factors driving their information choices and educational needs. A must listen for those looking to advance their HCP engagement with practical tips to enhance your medical education strategy.
AI and Generative AI seem to be a part of every webinar, conference, and conversation these days. Most of you are probably experimenting with AI for personal use and may even be having success with the use of AI in your day-to-day work. However, the technology and use cases are ever-evolving. Today's podcast will explore three proof-of-concept (POC) use cases from recent work in the field of Medical Information.
In this podcast, we explore how digitally active HCPs and emerging experts can amplify the impact of scientific data presented at congresses to drive successful drug launches. Industry experts from Pfizer and Veeva discuss strategies for engaging these key influencers to optimize launch success.
Overcoming regional disparities to ensure successful IEGP development and implementation requires effective strategies for cross-functional collaboration across diverse regions and departments. In this podcast, experts explore the many challenges associated with the operationalization of global Integrated Evidence Generation Planning (IEGP) at local levels.
This podcast speaks with experts from Altmetric to delve into different methods for extracting insights to comprehend the influence of a publication on key metrics such as citations, public engagement, social impact, and internal metrics. The aim is to speed up the evaluation process to determine if publications are effectively reaching and educating the appropriate HCPs to influence their clinical decisions.
This session takes a closer look at one of the key challenges associated with integrated evidence generation planning that was identified in our first installment. Experts share insights and practical advice on ways to identify and overcome barriers to aligning multiple functions in the development and implementation of integrated evidence generation plans to minimize risk and optimize value, accounting for medical affairs, patient, regulatory and commercial perspectives.
Recorded at the MAPS 2024 Annual Meeting in Puerto Rico following a workshop on modular content in which all of today’s speakers were faculty.
Lead by the Digital FAWG’s Jennifer Riggins and Steve Casey, today’s panelists touch on the topic of modular content in the following areas:
- Inspiration and Impact
- Content Compliance & Approval
- MSL Utilization
- Training & Evolution
- The Technology Stack
- The Future of Modular Content
For more information on Modular Content, explore the MAPS White Paper: “Modular Content in Medical Affairs: The Foundation of Omnichannel Engagement” HERE: https://medicalaffairs.org/modular-content-omnichannel-engagement/
As the sources of data and technologies needed to make sense of data expand, opportunities exist for further integrating Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) alongside traditional approaches when planning data generation activities to support new product registration, access, and use. Here we speak with experts from Lumanity about the Integrated Evidence Generation Planning (IEGP) process and how to overcome the barriers to success.
Here we speak with Kate Davies, Nurse Educator at London South Bank University and expert in clinical endocrine research focusing on genetics in short stature, clinical trials, and differences in sex development. Throughout Kate's research and work as a pediatric nurse, she has developed expertise in engaging with patient communities, often providing trusted information to these groups and also learning about the real-world experiences of patients in the context of treatment and clinical trials. Here is what a patient advocate wants Medical Affairs to know about patient engagement -- and join us at our LinkedIn discussion on this topic to ask your own questions about engaging with patients.
Getting the most impact from a publication requires being able to define who the audience is and how to reach them, across both journals and online channels, especially in complex/niche cases. In this podcast, we’ll discuss the benefits of taking an analytical approach.
When you think about innovation in Medical Affairs, perhaps the first things that come to mind are GenAI or maybe new approaches to KOL network mapping. But what about innovation in the ways we approach the profession itself? What about innovation in how we continue to evolve our own skills and understanding of our roles in industry and beyond? Here we speak with Tim Mikelhashvili, CEO of Amedea Pharma about innovation in Medical Affairs leadership -- and innovation for leaders. We also look forward to Tim's 2024 Medical Affairs Innovation Olympics. Enter your innovative idea now or register to attend!
A PubMed search on the day this was written finds 36,735 new publications in the last 24 hours. Adding the word “oncology” narrows the number to 4,334. Substituting “lung cancer” for “oncology” results in 534 articles. How many of these do you think your HCPs and KOLs will be able to read before the next batch of publications comes out tomorrow? This is to say that publishing a scientific study or article can feel like squeezing an eyedropper into the ocean and it is the job of the publication’s team to ensure this drop-in-the-ocean has impact — especially when publishing a study with the potential to change clinical practice. Here we learn practical tips straight from the source – namely, experts at Wiley. How can you translate peer-reviewed publications to clinical impact? How can licensing extend (or perhaps restrict…) the reach of published research? How can publications be leveraged as the hub of an omnichannel approach? Listen to learn more.
Is there a correlation between a higher journal impact factor and increased reach and engagement? The answer has always been, "Of course!" But now with companies driving their own engagement, and alternatives to the journals becoming more mainstream and accepted everyday, the answer is more nuanced. Join our expert guests from Digital Science to discuss the NEW metrics of journal publication.
In this podcast, we discuss a data-driven approach for optimizing congress planning and execution. MAPS speaks with experts from United Therapeutics and Veeva for tips on finding the right events, effectively engaging the right experts, and enabling medical teams to do more with less.
When Medical Affairs was a support function, it was enough to count the actions we performed to aid the missions of our collaborators in Commercial and R&D. Now that Medical is a strategic partner alongside these other functions, we must measure and message our OWN mission. But how can we draw a line of causality or at least contribution from actions to impact? Here we speak with Diana Morgenstern, MD, Fellow of the American College of Physicians, member of the MAPS EvGen Domain Team, and Executive Strategist in the IQVIA US Medical Affairs Center of Excellence, and Javier Lopez-Molina, MBA, Senior Director of in the US Medical Affairs Center of Excellence, IQVIA about exactly this challenge. And we ask a very important question: now that we appreciate the need to demonstrate impact and technologies exist that allow us to measure impact...what's holding us back?
As Medical Affairs professionals, many of us have moved from first careers in academia or healthcare. What did your colleagues say when you told them you were transitioning to pharma? Did they say you were going to the "dark side"? In this episode, we speak with Robert Atkinson, President of the Information Technology and Innovation Foundation and author of the recently published book, Technology Fears and Scapegoats: 40 Myths About Privacy, Jobs, AI, and Today’s Innovation Economy. And we explore the origins of negative opinions of the pharmaceutical industry, and whether a for-profit model can support both innovation and the society's best interests.
Modern scientific storytelling is about more than data dissemination — it's about creating meaning for the audience, and as such (as any good bard on the stool of a Medieval tavern knows) it requires truly understanding the audience's motivations and needs. However, scientific storytelling goes further. Our goals are not fiction nor purely entertainment — it's helping HCPs and KOLs make patients lives better. Here we talk about this approach with Murali Gopal, Vice President and Head of Medical Affairs at Phathom Pharmaceuticals and Dave Gulezian, co-Founder and CEO at Alucio. And we ask what is the ONE thing a company must implement in their transformation from the 40-slide deck to modern scientific storytelling. Spoiler alert: They actually agree and it's something that doesn't require budget.
We know the expectations of our job and we likely know the purpose of our organization. But what is the purpose of your role? What is the golden thread that guides your work? Does it connect to your personal purpose, your organization's purpose or both? Here we speak with Jill Donahue, author of the recently published (free!) book, "A Dose of Inspiration: 100 Purpose Stories from Pharma Leaders" about the individual and organizational benefits of discovering your purpose as an employee in the Life Sciences industry — as well as previewing some of the purpose stories Jill uncovered while writing the book.
Links:
A Dose of Inspiration: 100 Purpose Stories from Pharma Leaders
Article: Tired of Being Told You Went to the Dark Side?
Continuing Medical Education (CME) is transitioning from in-person, day-long seminars to bite-sized, virtual, learn-at-your-own pace courses. Here we talk with experts from Wiley and the world of consulting about new directions in CME — and how to address the continuing need for social learning and perceived authority even as we make information more consumable.
Many of us think about machine learning and AI as a way for an audience to get information: We ask ChatGPT a question and it provides the answer. Here we explore machine learning as a way to get information about an audience — both audience segments/personas and individuals within these groups. We also discuss the limitations and data privacy concerns that distinguish what we "could" know from what we "should" discover. And it turns out machine learning is not just a tool for mining he external environment, but also a way to make sense of a company's internal data to discover hidden experts and resources within the company.
In our last podcast episode of this series, we talked with Matt Lewis. We discussed generative AI, what it is and how it may change and evolve the medical communications environment. Today, we dive into a really important area that can significantly influence your GenAI results - Prompt Engineering and other areas.
In this podcast, we delve into the world of omnichannel strategies in Medical Affairs, where understanding your audience's educational needs and communication preferences is pivotal for delivering relevant and engaging data dissemination.
Join us as we explore how to develop effective communications by leveraging various sources of audience understanding, and how to translate information into actionable insights.
Discuss what the gold standard for insights could look like and highlight practical suggestions for how to yield robust insights while navigating common challenges often associated with using insights.
This podcast provides an overview into the multifaceted process of understanding your audience and explains the complexities and opportunities within the Medical Affairs space to ensure that your communications resonate with your audience, and ultimately, support their educational goals.
In Medical Affairs, our eyes are open to the vast possibilities of Artificial Intelligence — not only to make our current work more efficient, but to expand our capabilities in areas we never considered possible. Here, MAPS speaks with experts from Pfizer and Putnam Associates about the most exciting current uses of AI and also where we may be headed in the future. Join us for a wild ride through the possibilities of AI.
MAPS speaks with Liz de Somer, CEO of Medicines Australia and Sharon Winton, CEO of Lymphoma Australia to explore patient engagement from the perspectives of industry and patient associations. Liz and Sharon are also speaking about this topic at the MAPA/MAPS Medical Affairs Summit in Sydney, AU, Nov 8-10, 2023.
This podcast reviews new ways of identifying and quantifying opportunities for field medical impact with disease-state analytics. Industry experts from Pfizer and Veeva discuss how longitudinal patient-level data can pave the way for a more patient-centric way of informing and shaping Medical Affairs strategy and operations.
MAPS speaks with Amit Lalwani, omnichannel lead and executive committee member of Medical Affairs Professionals of Australasia and member of the core planning team for the MAPA/MAPS Medical Affairs Summit in Sydney, Australia, November 8-10.
When we look at AI, and in particular natural language processing, we think about how we can use these new tools in the medical information space. How do we see the new generative AI models changing what medical information has been doing, especially in the context of chatbots and information dissemination? In this podcast, we interview Matt Lewis, Chief AI Officer at Inizio Medical, a well-regarded expert in data analytics and augmented intelligence.
At MAPS Global 2023, “omnichannel in Medical Affairs” was a hot topic across numerous sessions. As part of the Field Medical track, Rosie Humphreys, Senior Director at OPEN Health, Donnie Wooten Jr., Global Head of Strategic Medical Content & Omnichannel at Organon and Kelly Lo, Field Medical Excellence, Global and Japan and Asia Pacific at Amgen conducted an interactive workshop, entitled “Optimize your Field Medical Team for the Omnichannel World”. Over 180 attendees, across two sessions, learned how an omnichannel approach is integral to maximizing Field Medical engagement with HCPs. This podcast will discuss the outcomes and insights of that workshop and how Field Medical can build skills and garner support to effectively implement omnichannel strategies.
Generative AI technologies are allowing Medical Affairs teams to find insights in more and more diverse data in less time and with more robust results. Here MAPS speaks with experts from Virtual Science AI including CEO, Tom Hughes, Chief Customer Officer, Geraldine Reilly, and Chief Technology Officer, Hans Chen about how this word, "Generative," has elevated the promise of AI — and how innovative Medical Affairs teams are leveraging these technologies to provide value for their organizations while driving patient benefit.
This podcast shares results from the latest Wiley HCP survey, which studies the content habits and preferences of over 900+ HCPs, as well as what they mean for improving engagement with healthcare audiences. Listeners will learn practical tips from the experts on the tactics that are driving impact with today's clinicians.
Partially recorded at the MAPS America's Annual meeting in Nashville, members of the MAPS Digital FAWG interviewed representatives from seven organizations in the MAPS Partner Circle.
In this podcast, the FINAL part of this 3-part series, our experts in the Digital FAWG tackle the question of: “How does a Medical Affairs organization measure the success, or value, of omnichannel activities?"
Partially recorded at the MAPS America's Annual meeting in Nashville, members of the MAPS Digital FAWG interviewed representatives from seven organizations in the MAPS Partner Circle.
In this podcast, part 2 of a 3-part series, our experts in the Digital FAWG tackle the question of: “How does a Medical Affairs organization plan for integrating omnichannel activities?"
Partially recorded at the MAPS America's Annual meeting in Nashville, members of the MAPS Digital FAWG interviewed representatives from seven organizations in the MAPS Partner Circle.
In this podcast, part 1 of a 3-part series, our experts in the Digital FAWG tackle the question of: “How do you define omnichannel,” with the hopes of helping listeners improve their understanding of omnichannel, the many definitions of omnichannel, and why it is difficult to implement in Medical Affairs.
Welcome to Part 2 of the MAPS Field Medical Focus Area Working Group's two-part podcast series entitled "Communicating the Value of Field Medical". In this second episode, experts from the FAWG will discuss Field Medical with the following goals in mind:
- The participant will be able to learn tips on how to explain the Field Medical value proposition to external stakeholders
- Learn how to adapt the proposition when you have just a short time in which to explain it
- Learn how to adapt the proposition to connect to medical customers more quickly
Welcome to Part 1 of the MAPS Field Medical Focus Area Working Group's two-part podcast series entitled "Communicating the Value of Field Medical". In this first episode, experts from the FAWG will discuss Field Medical with the following goals in mind:
- To help the listener communicate the value of Field Medical to internal stakeholders
- Explain how to integrate the qualitative and quantitative measures when communicating Field Medical value to internal stakeholders
- Discuss how to build relationships and engage with internal stakeholders
In a post-COVID world, HCPs want to access industry information through self-service content that is available anytime, anywhere — before they engage with representatives from the company. Most companies are aware of this trend. However, most industry organizations are not equipped with the modular content and online platforms needed to deliver this Netflix-like engagement. Here MAPS speaks with Bozidar Jovicevic, MD, MBA, former pharma executive, CEO and cofounder of Evermed, about best practices for gathering content (beyond simply creating it yourself!), and making content accessible in modern, personalized platforms.
One of the great challenges in Medical Affairs is understanding our opinion and communication networks. Over the last few years, the diversity of stakeholders involved in communicating, advocating, treating and responding to our work has become more complex and dynamic. At the same time, communication routes have proliferated and opened, taking us away from our traditional channels. This wealth of data can be overwhelming.
In this podcast, Carlos Areia and Mike Taylor - two data specialists at Digital Science - discuss the ways in which Medical Affairs professionals can use this data to discover your next generation of researchers, those influencers whose voices are heard on Twitter, and how your KOLs are interacting with others online, and which publications they're discussing.
Today’s podcast objectives are for listeners to better understand:
- What innovative content is in the context of Medical Information
- Expectations of HCPs in accessing innovative content
- And key learnings in the transition toward the use of more innovative content.
During Covid, many companies developed capabilities to provide eLearning resources, both for internal training and for external education. In this episode, MAPS speaks with Sucharita Kundu, Senior Content Strategist at Wiley and Professor Michael Kirby, currently the Editor of Trends in Urology & Men’s Health about best practices for eLearning development and publication. We've transitioned from eLearning provided from a company-centric perspective to courses designed based on deep understanding of an audience's content needs and interaction preferences. This episode teaches listeners to create eLearning resources that are relevant, credible and evidence-based.
The goal of all Medical Affairs activities is to improve patient outcomes. That said, until recently, we have measured our progress toward this goal by fairly distant proxy — for example, tracking the number of MSL/HCP interactions as a proxy for providing education that we hope will result in changes in clinical practice. In this episode of the MAPS podcast series, "Elevate", Ariel Katz, co-Founder and CEO of H1, provides a more linear and streamlined vision for how Medical Affairs can impact patient outcomes — and how to measure the results of our actions.
The role of real-world evidence (RWE) in Medical Affairs has greatly evolved in the last few years. The clinical evidence regarding the potential benefits or risks of a therapy generated from data relating to patient health or the delivery of health care can add value at every stage of a product’s lifecycle. RWE can not only help support a product’s safe and appropriate use in a post-approval setting, but the data can also inform innovation, trial design, personalized medicine, regulatory filings and optimize decision-making for better patient outcomes. In this episode, we hear from RWE and industry experts on the importance of early alignment of your evidence generation plan and medical strategy and how to integrate RWE into your publication plan.
Conference prep requires more than placing publications, securing booth space and scheduling as many KOL meetings as possible. Here we speak with Chris Medieros, Director of Strategic Insights, H1, about how to maximize your organization's presence and impact at congresses, including how to plan strategically across the workflow of KOL interactions.
In today's episode of the MAPS "Elevate" podcast, we'll be looking at considerations for Medical Affairs in Rare Disease and Gene Therapy and reviewing the following questions:
- How do you the see the role of Medical Affairs evolving in the era of advance therapeutics like gene therapy, often investigated for rare disorders? Are there specialized skillsets MA professionals need to be successful in this area?
- What are three major differences in approach to Med Affairs planning in rare disease, whether or not there is a gene therapy involved?
- From your experience, what are the biggest hurdles for Med Affairs professionals educating HCPs on gene therapy? It sounds really exciting in concept, but does the reality differ in practice?
- What advice is there for Med Affairs colleagues wanting to work in either rare disease or gene therapy? Are there specialized roles coming up in this space, different from current roles?
This series of the Elevate Podcast illuminates the path scientific communication takes from teaching to diagnosis to treating all the way to changing, prolonging, and saving patient lives. External Education of a growing variety of stakeholders in healthcare by the Medical Affairs Division of Pharma and Medical Device industry reflects the critical role Education in Medicine plays in our Age of Information. The podcast features critical discussions with leading educators across healthcare from the various perspectives of pharma / biotech sponsors, program organizers, attendees, and patients with a quest to explore some of the most novel, intriguing formats of Medical Education, following their approaches to learning in our digital age as well as their current gaps or success stories. The goal of the podcast is to make medical education simpler to access, more relevant to apply across healthcare organizations, and more continuous to inspire innovation and quality.
This second episode in the series discusses the activities of the External Education FAWG and the different learning opportunities that are currently available and coming soon to all MAPS members. Our host, Tim Mikhelashvili, PharmD, Co-Founder and CEO of Amedea Pharma and Chair of the Mentorship Program at the Medical Affairs Professional Society (MAPS) speaks with Sarah Funderburk, SVP Senior Medical Strategy Director with Caudex and Partner Circle member of the External Education FAWG. Sarah discusses some of her learnings from the area of company-led education and her vision for where emerging technologies could take medical education in the future. She addresses the gaps in personalizing education for healthcare consumers and providers based on Salesforce’s latest global Connected Health Consumer Report, and reviews the role of programs such as ChatGPT, Tome, and Synesthesia on medical education. Listen to the episode to hear how, when and where you can take advantage of the many exciting activities being offered by the External Education FAWG.
In this episode of the Elevate podcast series, MAPS speaks with experts from Altmetric about tackling the challenges of an expanding world and understanding who is communicating research by measuring Share of Voice.
This episode is sponsored by Altmetric.
- How and why medical publishing is changing and where is it going in the future.
- The benefits of digital-first development of manuscripts.
- How enhanced content can improve publication access and resonance.
MAPS speaks with Tim Mikelhashvili and winners of his Medical Affairs Innovation Olympics about applications that can match patients with clinical trials and provide real-time input to provide context for clinical decisions.
When we think about Medical Insights, the first function that comes to mind is Field Medical and capturing/analyzing MSL/HCP interactions in ways that lead to strategic actions. But there are other sources of insights, including the Medical Information function. Many organizations are already capturing and quantifying MedInfo requests to learn more about the types of questions HCPs are asking. Now tools exist to look deeper into this data, allowing MedInfo teams to truly contribute to the generation, analysis of Medical Insights. Learn more in this episode of the MAPS podcast series, Elevate.
On today's episode, we're Speaking with Tim Mikhelashvili, CEO and Co-Founder of Amedea Pharma, and the winners of his Medical Affairs Olympics Competition who dared to come together to share ideas across MA functions.
This podcast is sponsored by Amedea Pharma.
This series of the Elevate Podcast illuminates the path scientific communication takes from teaching to diagnosis to treating all the way to changing, prolonging, and saving patient lives. External Education of a growing variety of stakeholders in healthcare by the Medical Affairs Division of Pharma and Medical Device industry reflects the critical role Education in Medicine plays in our Age of Information. The podcast features critical discussions with leading educators across healthcare from the various perspectives of pharma / biotech sponsors, program organizers, attendees, and patients with a quest to explore some of the most novel, intriguing formats of Medical Education, following their approaches to learning in our digital age as well as their current gaps or success stories. The goal of the podcast is to make medical education simpler to access, more relevant to apply across healthcare organizations, and more continuous to inspire innovation and quality.
This is a first of a series of episodes that examines the podcast as one of the most effective emerging channels and formats of education in medicine. Our host, Tim Mikhelashvili, PharmD, Co-Founder and CEO of Amedea Pharma and Chair of the Mentorship Program at the Medical Affairs Professional Society (MAPS) speaks with Shelby Englert, Vice President of Education at the American Urological Association to learn why podcasts are powerful from a Professional Medical Society’s perspective. Shelby explains why its organization started its AUA University podcast, now with 165 episodes and the role it has played in building and growing its community of urologists in the association. She also describes how the AUA University podcast is structured, how it has evolved over time, and shares personal suggestions for elements of education most valuable and relevant to an audience in a podcast, providing specific examples that demonstrate the direct impact of the podcast on patient and physician behaviors as well as health outcomes. Listen to this episode because it not only centers on the ultimate impact of podcasts on the quality of medical education, but also discusses all the “supporting players” and “accessories” to the podcast required such as channels, technology, and timing of podcast communication to make a podcast successful and valuable in healthcare.
How do you deliver impactful medical education? Hear from industry experts how to design medical education programs successfully for today’s healthcare professionals, in our latest podcast episode, sponsored by Wiley.
In today's episode, we're talking with Joseph Zabinski, PhD, Senior Director, AI & Personalized Medicine at OM1 about Artificial Intelligence — specifically about how AI can accelerate diagnosis and treatment. This episode is sponsored by OM1.
Today we're talking about publications impact with Mike Taylor, Head of Data Insights and GRONYA Farrell, Manager Corporate Life Science, Central Europe, both at Digital Science. We'll discuss the questions:
- Where are we now?
- Are we looking beyond impact factor?
- And how to do we make sense of the data and translate "numbers" into "actionable insights".
This episode is sponsored by Digital Science, choosing journals and understanding publication impact in the digital age.
Post-approval safety studies have traditionally been cumbersome and expensive, and safety study sites are likely to mirror those used in clinical trials, leading organizations to potentially miss safety signals in populations beyond those that typically participate at trial sites. Here we speak with Stefan C. Weiss, MD, Managing Director, Dermatology at Om1 about a transformation in the way we conduct safety studies — relying on EMR patient data overlain with technology to create a more accurate and equitable view of post-market safety.
As technology changes the ways we engage with external stakeholders, the skills we need to manage these interactions are changing, as well. Here we speak with Jen Millard, Vice President of Field Medical at IQVIA, about emerging competencies for external engagement. This episode is sponsored by IQVIA.
Patient communities continue to mobilize and play an increasingly important role by influencing many elements of the drug development journey and subsequent patient access and support activities. This input ranges from natural history studies, recruitment in clinical trials, understanding burden, contributing to Health Technology Assessments and co-creating educational resources that enable shared decision making and adherence support. Given Medical Affairs stakeholders have similar reach across drug development and commercialization it is logical that this function plays a central role in an organization’s patient-first thinking and strategy. To achieve this, Medical Affairs stakeholders will need to develop thoughtful and impactful strategies that not only build the trust of patient communities but also their internal colleagues. Here we discuss patient-centricity strategies and actions with Gavin Jones, Global Advisor Rare Disease, OPEN Health, Jenny Ghith, Senior Director, Omnichannel Strategy and Innovations Lead, Pfizer, and Brittany Wolf, Director, Patient Centricity Lead, Pfizer.
This podcast series focuses on how digital is transforming scientific communications.
In this, our second episode this season, we'll be discussing open access in medical publishing from the biopharma perspective.
In this Opening Doors episode of the Medical Affairs Professional Society podcast series, Elevate, we speak with Áine Prendergast, Medical Science Liaison in Oncology with Ipsen. Hear about Áine's path into the profession and learn important advice that can help you find a first MSL position.
In this second podcast in this series, we will discuss delivering constructive feedback.
On today's episode of the MAPS "Elevate" podcast, we're discussing the use of Real-World Evidence to understand and possibly intercede in treatment-resistant depression and why is it especially difficult to develop treatments against resistant depression using the traditional structure of R&D-led clinical trials.
This podcast series focuses on how digital is transforming scientific communications. Season 2 Episode 1 will focus on the struggles and successes of compliance in Medical Communications. Season 2 Episode 2 will focus on the journal publishing industry, discussing how medical journal publishing is transforming and what changes we might see in the future. Season 2 Episodes 3 and 4 will focus on open access and how we can make scientific information more accessible and open access more transparent.
Description and Objectives:
Our podcast objectives are for listeners to better understand:
· Compliance issues and considerations facing publication professionals,
· The transparency complexities encountered by publication professionals
· And concerns related to the use of publications in downstream deliverables
Opening Doors episodes of the MAPS Elevate Podcast Series give Medical Affairs professionals the opportunity to tell the story of how they found their way into the profession and to offer advice to others seeking Medical Affairs positions. Here MAPS co-founder, Kirk Shepard, speaks with Niha Yerneni, Medical Scientific Affairs Manager at Ironwood Pharmaceuticals about joining Medical Affairs and, among other ideas, whether a person with recent postgraduate degree (MD, PhD, PharmD) can be successful in immediately seeking a position in industry or if fellowship or other industry training opportunities are necessary gatekeepers for entry.
With the evolving role of Medical Communications in Medical Affairs, greater partnership and integration in Medical Strategy Planning is key to improve overall Medical Affairs outcomes. Enhanced collaboration between these groups drives strong MedComms execution, leading to increased awareness in the HCP, payer, and regulatory communities. During these podcasts, experienced Medical Strategy and Communications leaders will discuss how you can structure roles and responsibilities, KPIs, and best practices to increase synergy between teams.
Learning Objectives
- Defining key performance indicators
- Best practices for measuring success of the Medical Strategy and Medical Communications strategy
- Share experience on insights communication between the two groups to refine strategy
The pharmaceutical and MedTech industries, and specifically Medical Affairs knows how far we are behind big tech in our ability to mine data for meaning. Here MAPS speaks with Mark Michalski, former radiologist and currently Worldwide Head, Healthcare & Life Sciences, Artificial Intelligence and Machine Learning, Amazon Web Services about how we can catch up — from predictive analytics in the .com experience to graph databases and other ways to structure data from the cloud.
With the evolving role of Medical Communications in Medical Affairs, greater partnership and integration in Medical Strategy Planning is key to improve overall Medical Affairs outcomes. Enhanced collaboration between these groups drives strong MedComms execution, leading to increased awareness in the HCP, payer, and regulatory communities. During these podcasts, experienced Medical Strategy and Communications leaders will discuss how you can structure roles and responsibilities, KPIs, and best practices to increase synergy between teams.
Learning Objectives
- Defining the roles and responsibilities of Medical Strategy and Medical Communications
- Communicate best practices in partnering to develop the Medical Strategy and Medical Communications Strategy
- Discuss ideas for measuring the impact of the Medical Strategy and Medical Communications Strategy
Congresses have traditionally been an important opportunity for Medical Affairs to present data while connecting with scientific leaders. But when the world went virtual during the pandemic, there were certainly some things we lost. So, what are the opportunities we gained?
In this episode of the Elevate podcast series, we speak with experts Felix David and Richard Donnelly about the tips and tricks to navigate through peer-review and get sponsored content published.
Measuring what really matters is often not straightforward, sometimes expensive, and always takes committed upfront thinking and planning. In this third and final podcast episode in this series, we will discuss measuring and improving the reach and engagement of scientific publications.
What do you need to consider when thinking about measurement, and what might this look like in practice? In this second podcast of a 3-part series, we will discuss considerations for measurable engagements in Medical Affairs.
We’re sensing a shift within Medical Affairs to make the case for and insist on better measurement, but how do we actually make that a reality? Measuring what really matters is often not straightforward, sometimes expensive and always takes committed up-front thinking and planning. In this first podcast of a 3-part series, we will address this question and discuss: The fundamentals of effective measurement techniques for Medical Affairs.
In this series, brought to your by the MAPS Field Medical Focus Area Working Group, we will be highlighting skills, topics and behaviors that are fundamental to Field Medical success. In this first podcast we will discuss leading through change .
In the final of this 3-part series, we will be meeting with Georgios Tramountanis, a member of the MAPS Digital Focus Area Working Group.
The podcast objectives are to:
- Examine where we see the potential opportunities for Medical Affairs as it relates to Automation
- Discuss what the best places to consider are when developing an Automation journey in Medical Affairs and where to start
- Review some predictions on the future of Automation in Medical Affairs.
On today's "Elevate" podcast episode, we're speaking with Eric Peacock, co-founder and CEO of MyHealthTeam about Medical Affairs work with patients in social networks. This episode, sponsored by MyHealthTeam, will address the following questions:
- What's the big opportunity for Medical Affairs professionals in patient social networks?
- What have you learned that works in engaging people living with chronic conditions?
- What role do social networks play in addressing inequities in healthcare?
- How has the approach to serving patients evolved over the past 10 years?
- What's the top takeaway from the pandemic that will impact future approach?
In this second episode, we'll be meeting with Shinya Suda-san, Sr. Vice President and Global Head of Information Systems at Astellas to glean insights on Automation opportunities as it relates to Digital Transformation.
The podcast objectives are to:
- Understand the potential opportunities that automation has already provided at Astellas Pharma
- Discuss any future expectations and predictions on how automation can be one of the enablers of a Digital Transformation journey
- Learn about Digital Transformation best practices and lessons learned
In this first of 3 episodes, we will be meeting with an industry expert on Automation within the pharmaceutical industry
The podcast objectives are:
- Understand key aspects of Automation to understand the potential opportunities
- Application of Automation within Medical Affairs – key examples and takeaways
- Recommendations on how to learn more and how to begin or accelerate your automation journey.
Attached to every clinical trial is a line of hope for a patient seeking a cure or better way to live with a rare, chronic, or limiting condition. Unfortunately, global events have disrupted the clinical trial landscape significantly in the past 2 years impacting the hope and lives of millions of people. Although rescue sites are most commonly thought of as an alternative to trials failing for more common reasons like lack of enrollment, Medical Affairs teams should be re-evaluating their overall strategy to make sure that even in the face of uncertainty, there is a path forward for clinical design. Rescue sites can provide that path forward.
In the midst of the COVID-19 pandemic, an informal cross-industry collaboration developed to share information and best-practices as they chartered into the unfamiliar territories of Emergency Use Authorization (EUA), the process, planning and preparation of the MI teams during a global pandemic. This podcast, a continuation from Episode 1, will discuss the What of the collaboration– the specific topics covered by phactMI, a nonprofit collaboration of Medical Information leaders.
Objectives: The objectives for this podcast series are:
- Discuss the impact the conversations in the group had on your workstream and with your internal business stakeholders
- Identify the major lessons learned through the collaboration
- Discuss how these lessons can be applied in the future
In the midst of the COVID-19 pandemic, an informal cross-industry collaboration developed to share information and best-practices as they chartered into the unfamiliar territories of Emergency Use Authorization (EUA), the process, planning and preparation of the MI teams during a global pandemic. This podcast will discuss the how and why this group of MI professionals, who are part of phactMI, a nonprofit collaboration of Medical Information leaders, came together and the lessons learned from their collaboration.
Objectives: The objectives for this podcast series are:
- Describe the motivation of the companies to participate in a collaboration.
- List the reasons for the collaboration to form.
- Identify the goals for the collaboration.
- Discuss the impact the conversations in the group had on your workstream and with your internal business stakeholders
- Identify the major lessons learned through the collaboration
- Discuss how these lessons can be applied in the future
In this episode of the Elevate podcast channel, Opening Doors series, MAPS co-founder Kirk Shepard speaks with Renu Juneja about her serendipitous path from a PhD program in India into the pharmaceutical industry. As Renu describes, she nearly quit science to take a retail management position to support her family, when she got an interview for a medical writing position at Novo Nordisk...and spent an afternoon sitting in Barnes & Noble to read up on what, exactly, a medical writer does.
In this episode of the Elevate podcast channel, Opening Doors series, MAPS speaks with Renu Juneja, who started a medical writing fellowship program at Janssen, and with two of her former fellowship participants, Jennifer Lee and Lauren Brown. We hope you enjoy this look at one way to find a first position in the pharmaceutical industry!
With a million records added annually to PubMed it's easy to get overwhelmed with new research. Not to mention the difficulty of evaluating the quality of research in smaller journals, not to mention preprints and emerging formats like indexed webinars. In this podcast, we speak with Tiago Barros, Managing Director of Faculty Opinions about the need for content curation to cut through the noise — and eventually provide patient benefit.
Medical Affairs has traditionally provided patient education by ensuring healthcare providers are up to date on the latest treatment, development and disease state information. Here MAPS speaks with Tim Mikhelashvili, CEO & Co-Founder, Amedea Pharma, and Riaz Abbas, Learning and Performance Lead, JAPAC Medical, Amgen, about innovative approaches to compliant patient education including communications with patient associations, the use of peer navigators, and the emerging use of social media.
MAPS Opening Doors podcasts feature short interviews with Medical Affairs professionals describing their path into and through the profession, and offering advice for job seekers and early-career professionals. In this episode, we speak with Richard Swank, Head, Global Field Medical, Amgen.
MAPS Opening Doors podcasts feature short interviews with Medical Affairs professionals describing their path into and through the profession, and offering advice for job seekers and early-career professionals. In this episode, we speak with Prem Sundivakkam, Director, Medical Affairs and Communications, Astellas.
MAPS Opening Doors podcasts feature short interviews with Medical Affairs professionals describing their path into and through the profession, and offering advice for job seekers and early-career professionals. In this episode, we speak with Leah Williams, Director, Medical Education and Communications, Hematology TA, CSL Behring.
MAPS Opening Doors podcasts feature short interviews with Medical Affairs professionals describing their path into and through the profession, and offering advice for job seekers and early-career professionals. In this episode, we speak with Ralph Rewers, Sr. Director, Head of Global MSL Excellence, AstraZeneca.
MAPS Opening Doors podcasts feature short interviews with Medical Affairs professionals describing their path into and through the profession, and offering advice for job seekers and early-career professionals. In this episode, we speak with Sherry Siegert, PharmD, Senior Director, Medical Affairs, La Jolla Pharmaceutical Company.
MAPS Opening Doors podcasts feature short interviews with Medical Affairs professionals describing their path into and through the profession, and offering advice for job seekers and early-career professionals. In this episode, we speak with Terry Griesing, PhD, VP, North America Medical Affairs, Pfizer.
MAPS Opening Doors podcasts feature short interviews with Medical Affairs professionals describing their path into and through the profession, and offering advice for job seekers and early-career professionals. In this episode, we speak with Omar McMillan, MSL Field Director, Oncology, Genentech.
MAPS Opening Doors podcasts feature short interviews with Medical Affairs professionals describing their path into and through the profession, and offering advice for job seekers and early-career professionals. In this episode, we speak with Nihar Baxi, Director, Global Medical Affairs, Astellas Pharma.
MAPS Opening Doors podcasts feature short interviews with Medical Affairs professionals describing their path into and through the profession, and offering advice for job seekers and early-career professionals. In this episode, we speak with Andree Amelsberg, VP, Medical Affairs Oncology, Esai US.
MAPS Opening Doors podcasts feature short interviews with Medical Affairs professionals describing their path into and through the profession, and offering advice for job seekers and early-career professionals. In this episode, we speak with Emily Howman, PhD, Senior Medical Strategy Lead, Envision Pharma Group.
Medical Affairs teams have generally gotten comfortable with the use of Real World Evidence (RWE) to answer questions that might previously have been the subject of clinical trials. Here, we speak with Dr. Ivy Weng, Head of Clinical Development & RWE/HEOR, Komodo Health about the use of RWE in not only reacting to questions but as a proactive piece of Medical Affairs strategy and clinical development.
MAPS speaks with Tim Mikhelashvili, PharmD, CEO & Co-Founder, Amedea Pharma, Inc. and Riaz Abbas, Learning and Performance Lead, JAPAC Medical, Amgen about innovative approaches to Medical Affairs External Education.
Working in rare disease offers Medical Affairs professionals the opportunity to engage directly with patient organizations and researchers/HCPs deeply involved in providing new options for patients who lack current treatments. However, working in rare disease also comes with significant challenges. Here MAPS sits down at our 2022 Global Annual Meeting with Catherine Parham, Vice President and Head of Global Medical Affairs at Astellas Gene Therapies to talk about the unique position of Medical Affairs in the rare disease space — and how our work in this area is essential for patient benefit.
Previous podcasts explore best practices for expert engagement, but MAPS Partner Circle member, H1, is in a unique position to notice patterns in the ways organizations struggle or simply fail to engage and support external experts. This episode of the Elevate podcast series details 4 things Field Medical teams can do better.
On this episode of the Medical Affairs Professional Society podcast series, "Elevate", we’re speaking about Health Equity with Ariel Katz, CEO of H1. Today, we'll be addressing what the role of Medical Affairs is in creating health equity, whether Medical Affairs is able to promote health equity in ways it couldn’t previously – or if Medical Affairs’ evolving role in health equity due more to increased awareness.
In this episode of the Medical Affairs Professional Society podcast series, "Elevate", we speak about embedding communications in Real-World Evidence strategy with Becky Galbraith, Senior Director, IQVIA Medical and Patient Communications and Barbara Arone, VP Medical Affairs Offerings, IQVIA. Specifically, we explore the necessity to consider communication as an essential element in the planning process for RWE studies. To learn more about how your organization can partner with IQVIA to discover and engage hidden thought leaders, visit Iqvia.com.
Medical Affairs is becoming more comfortable with the mechanics of digital listening to survey opinion and knowledge beyond our usual audiences. In this podcast we discuss two important categories of Digital Opinion Leaders (DOLs) we should all be listening to: Content Disseminators and Content Generators. According to our guest, Scott Thompson, Co-Chief Executive Officer at Acceleration Point, disseminators may help Medical Affairs spread knowledge, whereas generators may be important sources of insights. Check out this episode of the MAPS podcast series, "Elevate" to learn more.
Without the help of technology, transforming the output from engagement sessions into actionable insights can be a barrier to fast and precise decision-making. In this episode of the MAPS Elevate podcast series sponsored by Within3, you’ll learn how emerging technology can help Medical Affairs teams quickly understand the results of their engagements. Experts will demonstrate how to implement AI-powered natural language processing to gather, interpret and integrate insights to uncover the story in your data.
In this episode of the Medical Affairs Professional Society's Elevate Podcast series, we speak with presenters of the MAPS 2022 Global Annual Meeting session, “Developing and Executing and Integrated Medical Communications Strategy and Plan.” Topic covered include the planning basics, the evolution of the MedComms planning process, and new considerations for planning. Download the related white paper below. And we hope you will join this session Wednesday, March 23 at 11:30 at the MAPS Global Annual Meeting in New Orleans!
The second podcast of this two-podcast series continues our discussion on this critically important topic and discusses practical tips on how to incorporate cybersecurity into your own practices and devices.
The Objectives for this podcast are to understand:
- What is the legal basis for cybersecurity expectations?
- What are some of the right questions to ask to ensure user health and safety is not compromised?
- What should be considered if a device has a measuring function, or if it is connected to the energy source?
- What needs to be included in this new era of risk, and what are some good examples and common pitfalls related to medical device risk management?
Join presenters of the MAPS 2022 Global Annual Meeting session "The Great Debate: How Medical Affairs can best support internal and external collaborations in patient engagement," as they detail the unique role of Medical Affairs in patient engagement. What can be done to ensure the patient voice is not only included, but also applied cross-functionally? How are patients getting more involved with pharmaceutical companies? What aspects of patient engagement with the pharmaceutical industry could be improved? Preview these topics now and then join the discussion at the MAPS 2022 Global Annual Meeting in New Orleans, March 20-23.
Conventional engagement approaches are falling short for Medical Affairs teams who need to make increasingly fast and agile decisions. In the second episode of this tech-focused podcast series, you’ll learn how emerging tools can enable better collaboration and engagement with both internal and external stakeholders. You’ll see examples of how the industry is increasingly turning to a hybrid communications approach - incorporating a combination of over-time and real-time engagement to get more precise dialog, bring diversity to discussions and make better, faster decisions.
Real-World Evidence (RWE) is transforming the landscape of data that influences clinical decision-making and even regulatory approvals. Here, MAPS speaks with Cerise James, member of the MAPS Evidence Generation Focus Area Working Group about applications of Real World Evidence including FDA criteria for accepting RWE, types of data, RWE study designs and the Totality of Evidence approach. To learn more about the emerging uses of Real World Evidence, plan to attend Cerise's session at the MAPS 2022 Global Annual Meeting, March 20-23 in New Orleans, titled "Real World Evidence Applications and How it can Change Medicine and Biopharma."
Disconnected data sources and list-based approaches have traditionally hindered the expert identification process for Medical Affairs teams, leaving gaps where there should be insights. In the first episode of this tech-centered podcast series, learn how recent technological advances are helping teams more effectively find and engage with the right experts. Join leaders from the Technology and Medical Affairs industries to understand how to use integrated HCP data and network analytics to get faster, better insights from disease communities.
MAPS speaks with Tim Mikhelashvili about metrics to communicate the strategic value of Medical Affairs activities, and specifically about the Medical Productivity Index (MPI), which seeks to quantify aspects of Medical Affairs including the MSL/HCP relationship and an individual's impact on patient outcomes. To learn more about the MPI and to add your voice to further development of this important metric, join Tim and co-presenters March 21 at the MAPS 2022 Global Annual Meeting in New Orleans!
In this episode of the Elevate podcast series, MAPS speaks with Bozidar Jovicevic, former VP at Sanofi and Novartis and now a CEO of Evermed, about the opportunity the pandemic presented for pharma to rethink the ways they engage with HCPs. Gone is the model of HCPs being always available to MSL presenting a slide deck. Today, Medical Affairs teams are taking a technology-powered, HCP-centric approach to scientific exchange, using personalized, on-demand, video content and data to understand HCP preferences that can inform subsequent MSL interactions. Learn how your Medical Affairs team can implement a Netflix-like, education streaming strategy to obtain direct access to HCPs, engage them repeatedly, and accelerate product launches and adoption.
Medical Affairs is specifically tasked with optimizing the real-world use of new drugs and yet clinical trial participation remains an imperfect (at best) representation of real-world patient populations. This podcast details ways to identify and engage diverse patients in Medical Affairs clinical trials, empowering the function’s core mission to maximize the benefit of new pharmaceutical and MedTech products to patients in the wider healthcare landscape.
This podcast series will focus on how digital is transforming scientific communications. Episode 3 will focus on publication metrics, specifically on how article-level metrics are impacting and creating new opportunities for medical publication and what metrics we should be tracking.
As Medical Affairs professionals, we are starting to capitalize on the promise of Real-World Evidence. However, the more we accomplish, the more untapped potential we see. This podcast looks beyond the obvious uses of RWE to explore emerging opportunities for Medical Affairs professionals and teams to leverage this powerful source of data to benefit patients.
This podcast series will focus on how digital is transforming scientific communications. Episode 2 will focus on different forms of enhanced publication content (EPC) and new approaches that might change manuscript development.
Medical Affairs was conceptualized in a primarily executional role, closely linked with an organization’s sales function. Now, as Medical Affairs has become the organization’s voice of scientific expertise, and in a climate of increased patient-centricity and increased scrutiny, Medical Affairs has taken on an increasingly strategic role. Here MAPS speaks with Ariel Katz, co-founder and CEO of H1 Insights about the factors driving the evolution of Medical Affairs and look at the shape of the function in 2030 and beyond.
This podcast series will focus on how digital is transforming scientific communications. Episode 1 will focus on the journal publishing industry, discussing how medical journal publishing is changing and what changes we might see in the future.
In this podcast, Kirk Shepard, Chief Medical Officer & SVP, Head of Global Medical Affairs OBG at Eisai, speaks with Ghazaleh EA, pharmacist and new industry professional. The conversation explores Ghazaleh's path into Medical Affairs and covers topics including the transition from training to industry, the plusses and minuses of clinical practice versus direct industry involvement, internships, challenges of finding a first position, and how to discover your specialty within the function.
As we all know as per the FDA – October is ‘Cybersecurity Awareness Month’ and today we are going to talk and discuss about this critically important topic. Our objectives for this podcast are as follows:
-
What is medical device cybersecurity – why should you care?
-
Why does the FDA and other agencies care about medical device cybersecurity?
-
What are the regulatory expectations?
Objectives:
At the end of this series of podcasts, the participant will be able to:
- Discuss the functions and activities of key external stakeholders
- Identify potential areas for compliant collaboration by MSLs with Academic Drug Developers
This podcast sponsored by VISFO explores the past, present and future of the Medical Science Liaison role, from its origin as a primarily sales-focused transactional position, to one of increasing strategic importance to the organization in which MSLs engage in a two-way dialogue with HCPs, KOLs and others within the ecosystem of external stakeholders to drive better patient care.
Objectives:
At the end of this series of podcasts, the participant will be able to:
- Discuss the functions and activities of key external stakeholders
- Identify potential areas for compliant collaboration by MSLs with Patient Advocacy Groups
Historically, insight gathering in life science has been a fragmented process, when it should be viewed as a single endeavor. In this discussion sponsored by Within3, learn how to eliminate the insight gaps that occur due to disparate data sets, changing stakeholders, siloed information systems, and evolving scientific narratives throughout the product development lifecycle – and how Medical Affairs teams can achieve clarity, improve business function, and reduce risk with a holistic, technology-enabled approach.
Before the pandemic most MSL/HCP engagements and advisory boards were in-person. Then during the pandemic, we largely moved to synchronous virtual — aka, we conducted our in-person engagements on Zoom. Now as we start to look beyond the pandemic, innovative Medical Affairs teams are exploring alternatives to traditional engagements including platforms that allow asynchronous or “over time” engagement: KOLs interact with platforms and with each other on their own time, receiving information and offering feedback outside the model of a group discussion. This podcast sponsored by Impetus Digital explores the opportunities and benefits of platforms that deliver asynchronous engagement, noting dramatic increases in HCP/KOL participation and cost-per-word.
Objectives:
At the end of this series of podcasts, the participant should be able to:
- Discuss the functions and activities of key external partners
- Identify potential areas for compliant collaboration by MSLs with key external partners
Medical Affairs teams are no longer only a conduit of information from the organization to external stakeholders. Now, in addition to speaking, Medical Affairs knows how to listen. The things Medical Affairs hears in its interactions with healthcare providers, policy makers, and other thought leaders can form the basis of an insight: An "aha!" moment that can drive strategic decisions and actions. But what is an insight and what is just an observation? With the recent explosion of insights data, it can be hard to tell! In this podcast sponsored by Larvol, we speak with Medical Affairs insights experts about how to manage this flow of information back to the organization and how to help actionable insights float to the top of the information ocean.
Traditionally, most Medical Affairs interactions were in person, whether at scientific congresses, external education events, or through Field Medical interactions with healthcare providers and other thought leaders. Then during the pandemic, almost all interactions went virtual. And now we are emerging into a period of hybrid interactions — some external stakeholders prefer FTF, while others have seen the benefit in virtual engagements. In this podcast sponsored by Alucio, MAPS speaks with Medical Communications experts about this new hybrid environment and how content strategy can support the interactions of Field Medical, External Education, Medical Info and other functions within Medical Affairs.
Medical Affairs has always been positioned to find meaning in big data and now social media presents another place to look. How can Medical Affairs teams leverage social media to discover thought leaders? Are there insights hidden in online conversations? In this podcast sponsored by IQVIA, we speak with Tanmay Saraykar, Director of Social Media Insights at IQVIA, about these topics and more.
Objectives:
At the end of this series of podcasts, the participant should be able to:
- Discuss the functions and activities of key internal partners
- Identify potential areas for compliant collaboration by MSLs with key internal partners
In this MAPS podcast sponsored by IQVIA, we speak with John Eichert, Director the Thought Leaders Center of Excellence at IQVIA about scientific communications platforms and the combination of peer survey techniques with machine learning to identify key opinion leaders within local and regional networks who may not create large digital footprints through publications or social media but are nonetheless influential thought leaders in the healthcare landscape.
Objectives:
At the end of this series of podcasts, the participant should be able to:
- Discuss the functions and activities of key internal partners
- Identify potential areas for compliant collaboration by MSLs with key internal partners
MAPS speaks with Hywel Evans, Director of the IQVIA Natural Language Processing Insights Hub about NLP to generate medical insights.
Objectives: This session will provide: Overview of the Foundation of Medical Information, Enhancement Opportunities for Medical Information, and Medical Information Value to the Organization
Objectives:
At the end of this series of podcasts, the participant should be able to:
· Discuss the functions and activities of key internal partners
· Identify potential areas for compliant collaboration by MSLs with key internal partners
Objectives:
· What insights did we gleam from our learnings in the patient space
· How did we meet the needs of our patients to ensure a great experience
· Provide some examples of Medical Information patient strategy
At the end of this series of podcasts, the participant should be able to:
· Discuss the functions and activities of key internal partners
· Identify potential areas for compliant collaboration by MSLs with key internal partners
Objectives:
- Describe an innovative approach to understanding the needs of our patients
- Understand how multiple functions in a pharmaceutical company can collaborate and work towards a common mission for patients.
Objectives
At the end of this series of podcasts, the participant should be able to:
- Discuss the functions and activities of key internal partners
- Identify potential areas for compliant collaboration by MSLs with key internal partners
Objectives
At the end of this series of podcasts, the participant should be able to:
- Understand the core goals and activities that support patient centricity within Medical Information
- Discuss how Medical Information colleagues can support patient-centric initiatives
- Provide examples of Medical Information patient strategy activities
Objectives
At the end of this series of podcasts, the participant should be able to:
- Discuss the functions and activities of key internal partners
- Identify potential areas for compliant collaboration by MSLs with key internal partners
At the end of this series of podcasts, the participant should be able to
- Understand how the in-person conference experience has changed and adapted to the virtual environment
- Discuss styles and formats that uniquely suit the online virtual conference experience
- Consider factors for enabling networking and interaction in online virtual conferences
Objectives:
At the end of this series of podcasts, the participant should be able to:
- Discuss the functions and activities of key internal partners
- Identify potential areas for compliant collaboration by MSLs with key internal partners
Objectives:
- Understand how the in-person conference experience has changed and adapted to the virtual environment
- Discuss styles and formats that uniquely suit the online virtual conference experience
- Consider factors for enabling networking and interaction in online virtual conferences
MAPS speaks with Natalie Yeadon of Impetus Digital about best practices for virtual Medical Affairs events emerging from the pandemic.
Objectives:
At the end of this series of podcasts, the participant should be able to:
· Discuss the functions and activities of key internal partners
· Identify potential areas for compliant collaboration by MSLs with key internal partners
Objectives
At the end of this series of podcasts, the participant should be able to:
- Understand how the in-person conference experience has changed and adapted to the virtual environment
- Discuss styles and formats that uniquely suit the online virtual conference experience
- Consider factors for enabling networking and interaction in online virtual conferences
Objectives:
At the end of this series of podcasts, the participant should be able to:
- Discuss the functions and activities of key internal partners
- Identify potential areas for compliant collaboration by MSLs with key internal partners
Part two in the series of MAPS HEOR Podcasts sponsored by the AlphaGroup of Medical Communication Companies. This Podcast features Dr. Kent Summers and Dr. Steve Camper discussing the collaboration of Medical Affairs teams with Health Economics and Outcomes Research.
Objectives
At the end of this series of podcasts, the participant should be able to:
- To Introduce the listener to what are social listening insights
- Discuss potential opportunities and challenges when instituting social listening insight
- Value and impact of social listening insights on Medical Strategy
- And finally Technology considerations and manpower needed
Objectives:
At the end of this series of podcasts, the participant should be able to:
- Discuss the functions and activities of key internal partners
- Identify potential areas for compliant collaboration by MSLs with key internal partners
The objective of this podcast is to discuss how the 21st Century Cures Act has led to new initiatives at FDA involving Real World Evidence. We will also examine some case studies where biopharma and medical device companies used Real World Evidence in innovative manners to obtain product regulatory approvals.
In this MAPS podcast, we speak with Luca Dezzani, Franchise Head Immuno-Oncology, AstraZeneca and Bruno Larvol, CEO and founder of LARVOL, about the emerging uses of social media in the practice of Medical Affairs including best practices and compliance concerns for Medical Affairs professionals participating in the social media landscape.
Objectives:
At the end of this series of podcasts, the participant should be able to:
· Discuss the functions and activities of key internal partners
· Identify potential areas for compliant collaboration by MSLs with key internal partners
Moderator: Kathryn Gann, PhD, Independent Consultant
Interviewer: Robert Groebel, VP, Global Medical Strategy, Monocl
Speaker: Ricardo Maamari, MD, NCMP, Global Medical Executive Director, Established/Optimized Portfolio and Rare Diseases, Novartis
The podcast objectives are to :
· Discuss some of the common challenges Medical Affairs organizations face in offering best-in-class digital capabilities to its customers.
· Offer some insights and perspectives both internally and externally to understand what opportunities exist to overcome these challenges.
Objectives:
At the end of this series of podcasts, the participant should be able to:
- Discuss the functions and activities of key internal partners
- Identify potential areas for compliant collaboration by MSLs with key internal partners
Moderator: Kathryn Gann, Independent Consultant
Interviewer: Donna Holder, PharmD, Senior Director, Global MSL Excellence, Daiichi Sankyo, Inc,
Speaker: Mary Beth DeYoung PhD, Publications Lead, AstraZeneca
The podcast objectives are to :
- Discuss some of the common challenges Medical Affairs organizations face in offering best-in-class digital capabilities to its customers
- Offer some insights and perspectives both internally and externally to understand what opportunities exist to overcome these challenges.
Moderator: Rishi Ohri, MBA, MS, Sr. Director MA Digital Excellence, Astellas Pharma
Interviewee: Jonathan Davies, MSc, Vice President Operational Excellence, Medical Affairs, Astellas Pharma
At the end of this series of podcasts, the participant should be able to:
· Discuss the functions and activities of key internal partners
· Identify potential areas for compliant collaboration by MSLs with key internal partners
The podcast objectives are to :
· To discuss some of the common challenges Medical Affairs organizations face in offering best-in-class digital capabilities to its customers.
· To offer some insights and perspectives both internally and externally to understand what opportunities exist to overcome these challenges.
Moderator: Rishi Ohri, MBA, MS, Sr. Director MA Digital Excellence, Astellas Pharma
Interviewee: Robert Stevens, Vice President & Global Head, Digital Medical Affairs, Novartis Pharma AG
Objectives:
At the end of this series of podcasts, the participant should be able to:
· Discuss the functions and activities of key internal partners
· Identify potential areas for compliant collaboration by MSLs with key internal partners
Moderator: Kathryn Gann, Independent Consultant
Interviewer: Amanda Logue, Oncology, Global MSL Excellence Director, AstraZeneca
Paul Naish, Director, UK Policy, AstraZeneca
The podcast objectives are to :
- explain what publication plain-language summaries are and how patients find them useful
- share patient experience of being involved in reviewing PLS, and key points to consider from a patient’s perspective when developing PLS
Moderator: Karen King PhD CMPP, Head of Medical Strategy, Growth & Development, CMC Affinity, a McCann Health Company
Interviewee: Simon R. Stones BSc (Hons) MMRS, Health Advocate and Consultant, Collaboro Consulting
At the end of this series of podcasts, the participant should be able to:
· Discuss the functions and activities of key internal partners
· Identify potential areas for compliant collaboration by MSLs with key internal partners
Moderator: Kathryn Gann, Independent Consultant
Interviewer: Ralph Rewers, National MSL Director, Anti-Infectives/HCV/Virology, AbbVie
Guest: Shontelle Dodson, PharmD, Sr. VP of Health Systems, Astellas Pharmaceuticals
In this second of two episodes, John Pracyk, MD, PhD, MBA speaks with Patrick Vega of Vizient Advisory Solutions about ways that device companies can capitalize on the shift from inpatient surgical settings to hospital outpatient departments, ASCs and outpatient sites of care. Presenters hypothesize that device companies that better understand the outpatient setting can more effectively adapt their products, services and support to meet customer needs.
The podcast objectives are to :
- explain what publication plain-language summaries are and their value
- share Pharma experience of developing PLS, including how to overcome any Pharma specific challenges
Moderator: Karen King PhD CMPP, Head of Medical Strategy, Growth & Development CMC Affinity, a McCann Health company
Interviewee: Dheepa Chari, Head, Global Scientific Publications, Pfizer Oncology,
MAPS speaks with Kent Summers, HEOR Lead at AlphaGroup and Steve Camper, VP of Medical Affairs at Blue Earth Diagnostics, about building Health Economics and Outcomes Research capabilities within Medical Affairs.
Objectives:
At the end of this series of podcasts, the participant should be able to:
· Discuss the functions and activities of key internal partners
· Identify potential areas for compliant collaboration by MSLs with key internal partners
This episode of the MAPS podcast series, Elevate, explores the differing approaches applied in the pharmaceutical and device industries to understand the impact and approach to acquired and internally generated data, analytics, and insights play in delivering value.
The Series Podcast Objectives are:
- Understand how the medical affairs strategic planning process can drive decision making throughout the year
- Gain insight into the value medical affairs bring across an organization when an effective, collaborative, aligned medical strategy plan is developed
- Obtain a working knowledge of how cross-functional teams within medical affairs can reference strategic plans to inform decision making and assess impact of efforts
Moderator: Monica DeAbadal, MD, MBA/HSA,VP, Medical Excellence, Ipsen
Speaker: Peter Piliero, MD, VP & Head, Medical Affairs Americas, GSK Consumer Healthcare
Speaker: Eileen K Sawyer PhD, Vice-President, Global Medical Affairs, UniQure ,
Speaker: Len Valentino, MD, President and CEO, National Hemophilia Foundation
Speaker: Anna Walz, CEO, MedEvoke
Even before the COVID-19 pandemic, the structure and content of interactions between MSLs and KOLs/HCPs was shifting, with MSLs increasingly seen as trusted partners in scientific exchange and KOLs/HCPs increasingly open to technology-based communications. Of course, the pandemic has accelerated this change, shifting the mechanics of communication and collaboration and throwing into focus the definition of “value.” This podcast presents the expertise of leaders from pharmaceutical organizations Pfizer and Nektar, as well as Larvol, focusing on how MSLs bring value to HCPs and KOLs during the time of pandemic.
Speakers:
· Tim Hylan, VP, Internal Medicine Field Medical Director Group at Pfizer
· Sue Currie, VP, Head of Medical Affairs at Nektar Therapeutics
· Bruno Larvol, Founder and CEO at Larvol
The Series Podcast Objectives are:
- Understand how the medical affairs strategic planning process can drive decision making throughout the year
- Gain insight into the value medical affairs bring across an organization when an effective, collaborative, aligned medical strategy plan is developed
- Obtain a working knowledge of how cross-functional teams within medical affairs can reference strategic plans to inform decision making and assess impact of efforts
Moderator: Monica DeAbadal, MD, MBA/HSA,VP, Medical Excellence, Ipsen
Speaker: Peter Piliero, MD, VP & Head, Medical Affairs Americas, GSK Consumer Healthcare
Speaker: Eileen K Sawyer PhD, Vice-President, Global Medical Affairs, UniQure
Speaker: Len Valentino, MD, President and CEO, National Hemophilia FoundationSpeaker: Anna Walz, CEO, MedEvoke
Objectives:
At the end of this series of podcasts, the participant should be able to:
· Discuss the functions and activities of key internal partners
· Identify potential areas for compliant collaboration by MSLs with key internal partners
In this third podcast episode in collaboration with Open Health, MAPS speaks with Jessica Ingram, Managing Director of Learning and Development at Open Health, and two of her team: Briony Frost, Learning Design and Development Specialist, and Jessamy Lowe, Senior Account Handler. Joining Jess, Jessie, and Briony is Seema Haider. Seema is the former Health Economics and Outcomes Research Cluster Lead for the Upjohn Business Unit at Pfizer. She also holds a Visiting Professorship at Hebei University, China, is a Faculty Lecturer at IFAPP-King’s College, London, and is an International Advisor for ISPOR India Chapter. In this podcast, they will be offering insights into metrics and how to measure the impact of internal training. . OPEN Health is a global, full-service medical communications agency offering Medical Affairs consultancy and content, publications, medical education and internal training.
In this second episode of the MAPS podcast series Elevate with medical communications and educational design experts from Open Health, we explore the development and delivery of internal training for Medical Affairs professionals: How do we ensure people do the training and can we also design for engagement and motivation? Does this look different in the digital environment?
Speakers include the following:
- Dirk Saerens, Scientific Knowledge Manager at Janssen EMEA
- Jessica Ingram, Managing Director, Learning & Development, Medical Communications, OPEN Health
- Briony Frost, Learning Design & Development Specialist, OPEN Health
- Ben Halford, Account Manager, OPEN Health
In partnership with Medical Communications and Educational Design experts from Open Health, this episode of the MAPS podcast series Elevate details how to position patients as priority in designing and refining internal training. How do we go about designing effective, outcome-focused internal training? Can effective internal training also be efficient? And is it expensive? What are the benefits for learners that you expect to result in benefits to patients? Join the following thought leaders for answers to these questions and more:
- Siobhan Mulhern-Haughey, Health Economics and Market Access Manager at Janssen EMEA
- Jessica Ingram, Managing Director, Learning & Development, Medical Communications, OPEN Health
- Briony Frost, Learning Design & Development Specialist, OPEN Health
- Rebecca Case, Account Manager, OPEN Health
Medical Affairs thought leaders discuss the Pre-21st Century Act uses of Real World Evidence (RWE) with Post-Marketing Surveillance to understand the impact of the 21st Century Act on RWE and Natural History Studies.
The Series Podcast Objectives are:
- Understand how the medical affairs strategic planning process can drive decision making throughout the year
- Gain insight into the value medical affairs bring across an organization when an effective, collaborative, aligned medical strategy plan is developed
- Obtain a working knowledge of how cross-functional teams within medical affairs can reference strategic plans to inform decision making and assess impact of efforts
Monica DeAbadal, MD, MBA/HSA, Vice President, Medical Excellence at Ipsen and MAPS Medical Strategy & Launch Excellence co-lead, culled out highlights from the Medical Strategy Strategy Planning live session at the March 2020 Annual MAPS Conference.
The session speakers who provided these critical intellectual components of Building the Medical Affairs Strategic Plan are: Peter Piliero, MD, Vice President & Head, Medical Affairs Americas at GSK Consumer Healthcare; Eileen K Sawyer, PhD, Vice-President, Global Medical Affairs, UniQure; Len Valentino, MD, President and CEO, National Hemophilia Foundation; and, Anna Walz, CEO of MedEvoke.
Kathryn Gann, Independent Consultant, serves as the moderator for this session on Global Communications. In this podcast, Robin Winter-Sperry, MD, President & CEO, Scientific Resilience, interviews Aimee Christian, Ph.D., Global Head of Communications, Specialty Care, Sanofi-Genzyme.
At the end of this series of podcasts, the audience should be able to:
· Discuss the functions and activities of key internal partners
· Identify potential areas for compliant collaboration by MSLs with key internal partners
In this first of two episodes, John Pracyk, MD, PhD, MBA speaks with Patrick Vega of Vizient Advisory Solutions about ways that device companies can capitalize on the shift from inpatient surgical settings to hospital outpatient departments, ASCs and outpatient sites of care. Presenters hypothesize that device companies that better understand the outpatient setting can more effectively adapt their products, services and support to meet customer needs.
External experts play a key role in the success or failure of the innovations delivered by the pharma/biotech industry. In today’s environment, restrictions continue to impede broad access to practicing physicians who in turn have less autonomy and it’s harder to gain access to them. At the same time, the complexity of the science behind future products increases the needs for diverse involvement aligned experts. Strategic engagement provides insights as new product develop, generate data, refine strategy and create relevant, credible and persuasive scientific communication. Thus relationships built and fostered through Medical Affairs are becoming more valuable in creating awareness and adoption.
This podcast will explore how successful expert relationships reflect trust and needs in long-term cooperation from both parties.
The Series Podcast Objectives are:
- Understand how the medical affairs strategic planning process can drive decision making throughout the year
- Gain insight into the value medical affairs bring across an organization when an effective, collaborative, aligned medical strategy plan is developed
- Obtain a working knowledge of how cross-functional teams within medical affairs can reference strategic plans to inform decision making and assess impact of efforts
Monica DeAbadal, MD, MBA/HSA, Vice President, Medical Excellence at Ipsen and MAPS Medical Strategy & Launch Excellence co-lead, culled out highlights from the Medical Strategy Strategy Planning live session at the March 2020 Annual MAPS Conference.
The session speakers who provided these critical intellectual components of Building the Medical Affairs Strategic Plan are: Peter Piliero, MD, Vice President & Head, Medical Affairs Americas at GSK Consumer Healthcare; Eileen K Sawyer, PhD, Vice-President, Global Medical Affairs, UniQure; and, Anna Walz, CEO of MedEvoke.
In this first of two podcasts, Pete Piliero, MD, VP & Head, Medical Affairs Americas, GSK Consumer Healthcare, moderates a discussion on Contributions Medical Affairs Makes to Asset Strategic Plans; and Time Horizon, Refreshing, and Resourcing of a Medical Affairs Plan.
Panelists are:
- Ed Gudaitis, MBA, President & CEO Acerus Pharma
- Keith Johns, MBA, VP, Global Marketing and Alliance Management, Eli Lilly & Co;
- Maria Rivas, MD, Chief Medical Officer, EMD Serono/Merck KGaA
In this second of two podcasts, Pete Piliero, MD, VP & Head, Medical Affairs Americas, GSK Consumer Healthcare, moderates a discussion on Global/Regional/Local Planning; Approach to MA Strategic Planning - Rare Disease & Oncology; and, Compliance Considerations.
Panelists are:
- Tina Beaman, VP and Chief Compliance Officer, Karyopharm Therapeutics
- Ed Gudaitis, President & CEO Acerus Pharma
- Keith Johns, VP, Global Marketing and Alliance Management, Eli Lilly & Co
- Maria Rivas, Chief Medical Officer, EMD Serono/Merck KGaA
Cerise James, MD, moderates this podcast presentation by the MAPS Evidence Generation Focus Area Working Group in which Neil Belson, JD, discusses Real World Evidence and its impact. The podcast objectives are: To define Real World Evidence, and to demonstrate RWE and its impact to Biotech/Pharma.
Mr. Belson will address a variety of topics including: The significance of Real World Evidence for the pharmaceutical and medical device industry; and, how the FDA views Real World Evidence.
This is the first podcast in a series.
In this second podcast on the EUMDR, panelists John Pracyk, MD, PhD, MBA, Worldwide Integrated Leader, Medical Affairs, Pre-Clinical & Clinical Research, DePuy Synthes - Spine | Johnson & Johnson Medical Devices Companies welcomes Philip Desjardins, JD, Vice President, Global Regulatory Affairs Spine and Medical Device Regulatory Policy, DePuy Synthes | Johnson & Johnson Medical Devices Companies, and Drilon Saliu, PharmD, MBA, Head, Medical, Clinical and HEOR, Connected Care, Philips, continue their comprehensive discussion of: Covid’s impact on EUMDR; USFDA and EUMDR global regulator comparison; short and long term impacts; how Brexit might impact the UK’s regulatory oversight; the importance of investing in top talent; new capabilities that are required; the importance of leading with influence; and, evidentiary compliance planning and budget impact.
Host John Pracyk, MD, PhD, MBA, Worldwide Integrated Leader, Medical Affairs, Pre-Clinical & Clinical Research, DePuy Synthes - Spine | Johnson & Johnson Medical Devices Companies welcomes Philip Desjardins, JD, Vice President, Global Regulatory Affairs Spine and Medical Device Regulatory Policy, DePuy Synthes | Johnson & Johnson Medical Devices Companies, and Drilon Saliu, PharmD, MBA, Head, Medical, Clinical and HEOR, Connected Care, Philips, to share insights into the importance of compliance with the new European Device Medical Regulation (EUMDR), including key deadlines for compliance.
If you’re considering a career transition, asking: “What’s in it for me?” is just as important as “What’s in it for the company?” During this podcast, Dr. Rubinstein asks the panelists, Dr. Sean Lilienfeld and Huub Kreuwel, why they considered making the change from one area to another. The potential for expanding your skillsets is an important consideration but it is not the only one.
Hosts John Pracyk, MD, PhD, MBA, Worldwide Integrated Leader, Medical Affairs, Pre-Clinical & Clinical Research, Depuy Synthes - Spine | Johnson & Johnson Medical Devices Companies and Marc Rubinstein, MD, Medical Director at Instrumentation Laboratory, welcome panelists Huub Kreuwel PhD, Vice President of Scientific and Medical Affairs at Octapharma, and Sean Lilienfeld MBBCh, MMEd(Neuro), FCP (Neuro), FAAN, a neurologist by training, and currently Vice President of Global Medical Affairs Clinical Operations, Pre-Clinical Research, and Clinical Strategy at Boston Scientific, two professionals who have successfully transitioned careers between MedTech and Pharma, and reciprocally, Pharma and MedTech.
What does it take to go from an external deep subject matter expert to an internal medical expert? Specializing in one area may limit your ability to transition from one therapeutic area to another; making this adjustment requires the ability to take a risk, the skills to gain trust, and comfort with admitting the limitations of your skill sets.
Teams are traditionally smaller in MedTech than in Pharma. In MedTech companies, the MA professional may be asked to manage smaller teams and broader areas of responsibilities. This may be the case if you work for a smaller Pharma company, but larger Pharma companies may require more focused responsibilities.
Do you possess the ability to empathize, but also the business acumen to understand your audience? MA professionals interact with a variety of stakeholders, so you must possess the skills necessary to be relatable and to present information in a meaningful way to a wide audience.
While there are similarities in decision making between Pharma and MedTech, it can be difficult to get face time with physicians but is still relatively easy to get face time with surgeons particularly when the medical technology is more complex. Asking what success looks like to the patient is a critical element in a successful career transition.
Ralph Rewers, PharmD, AbbVie’s Global Head, Field Medical Excellence pulled together a group of experts who will discuss the differences in the types of Field Medical that they’re looking to hire. This panel at the Field Medical session on March 8 in Miami includes Nancy Ortiz, PharmD, Executive Director, GMA & Field Medical at Stonebridge Biopharma, Steve McLaughlin, Regional Director, US Rare Disease Field Based MSLs, Sanofi Genzyme and Brooke M. Kim, RN, BSN, MSM who serves as the AbbVie National Director, Oncology Field Medical. The podcast will highlight topics to be discussed, such as rotational assignments, career ladders, and internal and external engagements
Change is the only constant in the MSL role. Panelists at the session of the March 8 Field Medical Program in Miami will prepare attendees by discussing influences on the MSL role, the rationale for emerging Field Medical roles, and key skill sets to ensure success. Speaking will be: John Pracyk, MD, PhD, MBA, DePuy Synthes – Spine, Johnson & Johnson Medical Devices Companies, Worldwide Integrated Leader, Medical Affairs, Pre-Clinical & Clinical Research, Chris Brock, PharmD, Field Based Medical Affairs Head, Respiratory at GlaxoSmithKline, Joseph Medicis, PharmD Executive Director and Head of Medical Affairs at Allena Pharmaceuticals, Michelle Powell, PharmD, Director, Field Medical Excellence, Astellas Pharma Global Development and Kyle Kennedy, VP, Customer Strategy at The Medical Affairs Company.
Host Robin Winter-Sperry MD, Head of Global Field Based Medical Excellence & Insights at Sanofi Genzyme introduces Donna Holder PharmD, Executive Director, Global Field Medical Center of Excellence (CoE) at Merck, and Ralph Rewers PharmD, AbbVie’s Global Head, Field Medical Excellence who organized this specialized course that is being offered at the MAPS annual meeting on March 8 in Miami.
Are you keeping up with the data and science that are driving the profession? The panelists who will be highlighting the critical importance of adult learning principles and certification of knowledge to career training insights on March 8 in Miami are: Donna Holder, PharmD, Executive Director, Global Field Medical Center of Excellence (CoE) at Merck, Stephen Valerio, MS, CMP, AstraZeneca Senior Director of Oncology Medical Training, Urvashi Vashee, PharmD, Team Lead Director, Global Scientific Training Oncology at Merck & Co, and Danielle C. Heuer, Director of WD Communications.
Patients want the best medicine and therapy available. Merinke Kuiper-Lenters, MD, a physician and patient who was diagnosed with autoimmune vasculitis, explains patient expectations from the pharma industry.
What does the future of MA look like from a commercial perspective? Robert "Bobby" Mulrooney, MD, General Manager, UK & Ireland for Portola Pharmaceuticals, shares his candid opinions as to how MA can be a driver of strategy with commercial partners.
How can global leaders set affiliates up for success? Charlotte Kremer MD MBA, EVP of Medical Affairs for Astellas, and current MAPS President, speaks to the importance of sharing information in real time.
In theory, successfully commercializing a product is straightforward; in reality it is not. In this comprehensive discussion, Matthew McLoughlin, MD, ex-Head of Advisory Services and Head of the Executive Committee for Kinapse is joined by Gustavo Kesselring MD, current Academy Vice President for the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) to discuss evidence generation to meet the needs of external stakeholders, the ability to bring actionable insights into the company, and the need for revamping of knowledge acquisition.
It's sometimes challenging to find insights that are actionable in development. In this podcast, Prof. Dr. med. Iris Loew-Friedrich, UCB Chief Medical Officer and member of the UCB Executive Committee and UCB Head of Development in Medical Practice, highlights her personal journey to help you understand how Medical Affairs is uniquely suited to address these issues.
It's sometimes challenging to find insights that are actionable in development. In this podcast, Iris Loew-Friendish, UCB Chief Medical Officer and member of the UCB Executive Committee and UCB Head of Development in Medical Practice, highlights her personal journey to help you understand how Medical Affairs is uniquely suited to address these issues.